Editorji is a digital news player, primarily in current affairs news content. It delivers news in two languages – English and Hindi and across three formats of video, audio, and text formats. One of the key features of the Editorji platform is its ability to generate personalised AI-driven news and information playlists. The Editorji algorithm pulls short-form video stories from partners and its own inventory to give a user complete information based both on what is important and what their preferences are.

Speechki: Easy Text-to-Speech for Everyone, Now with ChatGPT Plugin Discover Speechki, the simple and efficient text-to-speech platform designed for users of all ages and backgrounds. Backed by Greycroft, Alchemist, and the founder of Blinkist, Speechki offers over 500 AI-voices in 77 languages to cater to your audio needs. With over 500 voices in 77 languages, Speechki offers a wide range of audio options to suit your needs. Our ChatGPT Plugin, as the sole approved text-to-audio solution in the ChatGPT store, provides the easiest way to convert ChatGPT texts into ready-to-use audio! Turn any text into engaging audio using our user-friendly interface, and share your creation through a download link, audio player, or embeddable code. Embrace Speechki, and make your content come alive with just a few clicks.

—

SCALE AI is an industry-led consortium that shapes a new global supply chain platform, bolsters Canada’s leadership in artificial intelligence , and accelerates industry adoption of enabling technologies through collaborative and incremental projects. SCALE AI (Supply Chains and Logistics Excellence AI) has been incorporated and is now designated as an Innovation Supercluster Initiative.

Caristo Diagnostics Limited is a global leader in cardiac and vascular disease diagnostics and risk prediction. Founded in 2018 as a spin-out company from the University of Oxford, the world’s #1 research university, Caristo has developed a portfolio of imaging-based and AI-assisted platforms that can be applied to aid the prediction and diagnosis of heart attack, stroke, and diabetes. Caristo was highlighted by Nature in 2020 as one of the most exciting science-based companies to have emerged from academic labs. To-date Caristo has attracted over £23 million in venture capital investment (nearly US$30 million). Named first of “7 Technologies That Could Change Heart Healthcare Forevermore” by the Robb Report, the CaRi-Heart technology is Caristo’s flagship offering which aids coronary artery disease diagnosis with improved risk prediction. It applies advanced AI algorithms to routine cardiac CT scans to visualize and quantify coronary inflammation, which is the previously invisible root cause of the disease. Each patient’s CaRi-Heart Report includes several clinical results: (1) the patient specific Fat Attenuation Index (FAI), a novel and patented biomarker for the measurement of coronary inflammation, which indicates the patient’s risk in % relative to a matched peer group; (2) CaRi-Heart Risk, which assesses the absolute 8-year risk of a fatal heart attack (based on both coronary inflammation status and standard clinical risks factors); and (3) coronary plaque-specific characterization and quantification. The CaRi-Heart Analysis is supported by the CaRi-Heart software, which is cloud-based and agnostic to the type of scanner generating the routine cardiac CT images. The CaRi-Heart technology is CE Mark certified under the latest EU MDR with UKCA marking being received in September 2022. CaRi-Heart is limited to research use in the U.S. before the FDA grants marketing authorization. Multiple patents underpinning CaRi-Heart technologies have been granted in major jurisdictions around the world. In addition, exceptional validation results showing Cari-Heart’s ability to aid the prediction of heart attacks have been published in leading medical journals including the Lancet, JACC, European Heart Journal, and Cardiovascular Research. CaRi-Heart validation and implementation projects have been supported by multiple UK government grants and awards, including the NHS AI Stage 3 Award for real-world evaluation and implementation of CaRi-Heart care pathway in multiple NHS hospitals. With its deep clinical insights, proven validity and implementation readiness, the CaRi-Heart Analysis Service and the resulting new care pathway can transform cardiac care around the world by aiding in better prediction and prevention of future heart attacks.

AINA Software Inc is a Research and development company that is focused on creating meaningful AI solutions for both consumers and brands in the beauty industry. The word Aina means a mirror or reflection. At Aina, we have a deep understanding of the meaning behind the word "reflection." We believe that true beauty should be defined on your own terms, free from any external pressures or outdated standards. Aina should reflect the true, authentic you. Our philosophy at Aina is that it's Your Beauty, Your Rules! Aina is a cutting-edge AI-driven platform that combines users, brands and influencers on a unique platform that offers an end-to-end complete beauty experience. At the core of the platform sits our AI Aina, which speaks to and engages with users over time. Aina not only understands a user's biological self but also their core values and preferences, to offer tailored recommendations and expert insights to help achieve their skincare and beauty goals along their beauty journey. In addition, Aina not only offers recommendations and builds routines on the fly, but it can also help teach users beauty techniques and expand their knowledge. At Aina, we value: -Inclusivity: Every shade, every type, every YOU. -Personalization: Your beauty, your rules. -Empowerment: Take charge. Be YOU. -Community Building: Together, we're a masterpiece. -Ethical and Sustainable Practices: Beauty with a Conscience. -Trust and Transparency: Open books, open hearts. -Innovation: Always evolving, just like you. -Connection: Vibing with your beauty tribe. -User Experience: Smooth, sleek, simple. Driven by YOU. -People: Every face, every story, every journey.

DroneShield is a worldwide leader in Counter-UAS (C-UAS) security and technology. DroneShield develops multi-mission security solutions that protect people, organizations and critical infrastructure from unmanned system threats. Its leadership brings world-class expertise in engineering and physics, combined with deep experience in defense, intelligence, and aerospace.

—